Roche (OTCMKTS:RHHBY) Sets New 1-Year High – Here’s What Happened

Roche Holding AG (OTCMKTS:RHHBY)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $58.48 and last traded at $58.3125, with a volume of 321156 shares. The stock had previously closed at $57.79.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on RHHBY. Zacks Research raised shares of Roche from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. JPMorgan Chase & Co. upgraded shares of Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. The Goldman Sachs Group upgraded shares of Roche from a “sell” rating to a “hold” rating in a research report on Thursday, January 15th. Barclays raised shares of Roche from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 6th. Finally, Morgan Stanley reiterated an “underweight” rating on shares of Roche in a research note on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Roche has an average rating of “Hold” and a consensus target price of $57.00.

Roche Trading Down 0.2%

The company has a current ratio of 1.29, a quick ratio of 1.02 and a debt-to-equity ratio of 0.80. The stock’s fifty day moving average is $53.60 and its 200-day moving average is $46.54.

Hedge Funds Weigh In On Roche

Institutional investors and hedge funds have recently modified their holdings of the business. Sarver Vrooman Wealth Advisors acquired a new position in Roche in the 4th quarter worth about $287,000. Hantz Financial Services Inc. increased its position in shares of Roche by 164.9% in the fourth quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock valued at $4,112,000 after buying an additional 49,633 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Roche by 18.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 22,255 shares of the company’s stock worth $1,148,000 after buying an additional 3,456 shares during the period. S&CO Inc. lifted its position in shares of Roche by 2.5% during the 4th quarter. S&CO Inc. now owns 53,444 shares of the company’s stock valued at $2,767,000 after buying an additional 1,290 shares in the last quarter. Finally, HighPoint Advisor Group LLC grew its stake in Roche by 55.3% in the 4th quarter. HighPoint Advisor Group LLC now owns 16,515 shares of the company’s stock valued at $852,000 after acquiring an additional 5,882 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.